AG真人官方

FORT MYERS, Fla.--(BUSINESS WIRE)-- NeoGenomics, Inc. (鈥淣eoGenomics鈥� or the 鈥淐ompany鈥�) (NASDAQ:NEO), a leading oncology testing services company, today announced the Company will participate in the following investor conferences:

• William Blair 45th Annual Growth Stock Conference in Chicago, IL
  Company presentation on Tuesday, June 3, at 1:00 pm ET, accessible
• Jefferies Global Healthcare Conference in New York, NY
  Fireside chat on Wednesday, June 4, at 2:00 pm ET, accessible

Live and archived webcasts of the sessions may be viewed on the Investor Relations section of the Company鈥檚 website at .

About NeoGenomics

NeoGenomics, Inc. is a premier cancer diagnostics company specializing in cancer genetics testing and information services. We offer one of the most comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with innovative diagnostic and predictive testing to help them diagnose and treat cancer. Headquartered in Fort Myers, FL, NeoGenomics operates a network of CAP-accredited and CLIA-certified laboratories for full-service sample processing and analysis services throughout the US and a CAP-accredited full-service sample-processing laboratory in Cambridge, United Kingdom.

View source version on businesswire.com:

Investor Contact

Kendra Sweeney

[email protected]

Media Contact

Andrea Sampson

[email protected]

Source: NeoGenomics, Inc.